• Citer

Lenalidomide in relapsed refractory myeloma patients: Impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium

par Delforge, Michel;Michiels, A.;Doyen, Chantal;Kentos, Alain ;Van Droogenbroeck, Jan;Offner, Fritz;Bries, Greet;Demuynck, Hilde;Vekemans, Marie-Christiane;Meuleman, Nathalie ;Mineur, Philippe;Ravoet, Christophe;Depryck, B.;Van de Velde, Ann;Pierre, Pascal;Wu, K.L.;Schots, Rik
Référence Acta clinica Belgica (Ed. multilingue), 66, 5, page (371-375)
Publication Publié, 2011

Article révisé par les pairs

• Détails
• Contenu

Titre:	Lenalidomide in relapsed refractory myeloma patients: Impact of previous response to bortezomib and thalidomide on treatment efficacy. Results of a medical need program in Belgium
Auteur:	Delforge, Michel; Michiels, A.; Doyen, Chantal; Kentos, Alain; Van Droogenbroeck, Jan; Offner, Fritz; Bries, Greet; Demuynck, Hilde; Vekemans, Marie-Christiane; Meuleman, Nathalie; Mineur, Philippe; Ravoet, Christophe; Depryck, B.; Van de Velde, Ann; Pierre, Pascal; Wu, K.L.; Schots, Rik
Informations sur la publication:	Acta clinica Belgica (Ed. multilingue), 66, 5, page (371-375)
Statut de publication:	Publié, 2011
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Bortezomib
	Lenalidomide
	Multiple myeloma
	Thalidomide
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0001-5512
	info:doi/10.2143/ACB.66.5.2062589
	info:scp/84555196851
	info:pmid/22145272